Immediate Effect of Baricitinib on Arthritis and Biological Disease-Modifying Antirheumatic Drug-Induced Psoriasis-Like Skin Lesions in Two Patients with Rheumatoid Arthritis
Biological disease-modifying antirheumatic drugs (bDMARDs) are very effective for treating rheumatoid arthritis (RA). However, they sometimes induce adverse events such as psoriasis-like skin lesions. We describe psoriasis-like skin lesions that developed simultaneously with an RA flare in patient 1...
Saved in:
Main Authors: | Yoshifumi Tada, Nobuyuki Ono, Syuichi Koarada |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Rheumatology |
Online Access: | http://dx.doi.org/10.1155/2021/8876847 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent evidence comparing combination of conventional synthetic disease-modifying antirheumatic drugs with biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
by: Abhishek Zanwar, et al.
Published: (2017-01-01) -
RP105-Negative B Cells in Systemic Lupus Erythematosus
by: Syuichi Koarada, et al.
Published: (2012-01-01) -
Concordance between the Different Cardiovascular Risk Scores in People with Rheumatoid Arthritis and Psoriasis Arthritis
by: Cristina Gonzalez-Martin, et al.
Published: (2019-01-01) -
Usefulness of Sarilumab in Patients with Rheumatoid Arthritis after Regression of Lymphoproliferative Disorders
by: Yoshifumi Tada, et al.
Published: (2023-01-01) -
A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate
by: Walid Fakhouri, et al.
Published: (2020-04-01)